DGNOF.US DIAGNOS Inc

Healthcare Health Care Technology USA Stocks
0.2300 USD
Close of Nov 14, 2026
0.1300 0.3800
Market cap
USD 27.8M
P/E
-
P/B
59.37x
ROE
-663.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2026.

Is DGNOF.US undervalued?

Graham number

The Graham number of DIAGNOS Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DIAGNOS Inc fundamental analysis

No fundamental analysis for DIAGNOS Inc yet.

DIAGNOS Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DIAGNOS Inc

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields o…

Full company profile